This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Aug 31;1551(1):M11-8.

doi: 10.1016/s0304-419x(01)00022-1.

Bcr-Abl inhibition as a modality of CML therapeutics

E Buchdunger¹, A Matter, B J Druker

Affiliations

PMID: 11553417
DOI: 10.1016/s0304-419x(01)00022-1

Review

Bcr-Abl inhibition as a modality of CML therapeutics

E Buchdunger et al. Biochim Biophys Acta. 2001.

. 2001 Aug 31;1551(1):M11-8.

doi: 10.1016/s0304-419x(01)00022-1.

Authors

E Buchdunger¹, A Matter, B J Druker

Affiliation

¹ Novartis Pharma AG, Research Oncology, Basel, Switzerland.

PMID: 11553417
DOI: 10.1016/s0304-419x(01)00022-1

No abstract available

PubMed Disclaimer

Similar articles

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD. Morel F, et al. Eur J Haematol. 2003 Apr;70(4):235-9. doi: 10.1034/j.1600-0609.2003.00046.x. Eur J Haematol. 2003. PMID: 12656747
Chronic myelogenous leukaemia--new therapeutic principles.
O'Dwyer ME, Druker BJ. O'Dwyer ME, et al. J Intern Med. 2001 Jul;250(1):3-9. doi: 10.1046/j.1365-2796.2001.00823.x. J Intern Med. 2001. PMID: 11454136 Review.
Treatment of chronic myeloid leukemia with imatinib mesylate.
Ohno R. Ohno R. Int J Clin Oncol. 2006 Jun;11(3):176-83. doi: 10.1007/s10147-006-0582-5. Int J Clin Oncol. 2006. PMID: 16850123 Review.
The biology and treatment of chronic myelogenous leukemia.
Brunstein CG, Mcglave PB. Brunstein CG, et al. Oncology (Williston Park). 2001 Jan;15(1):23-31; discussion 31-2, 35. Oncology (Williston Park). 2001. PMID: 11271979 Review.
Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.
Sillaber C, Mayerhofer M, Agis H, Sagaster V, Mannhalter C, Sperr WR, Geissler K, Valent P. Sillaber C, et al. Wien Klin Wochenschr. 2003 Aug 14;115(13-14):485-504. doi: 10.1007/BF03041033. Wien Klin Wochenschr. 2003. PMID: 13677268 Review.

See all similar articles

Cited by

Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.
Kuo CY, Wang PN, Hwang WL, Tzeng CH, Bai LY, Tang JL, Chang MC, Lin SF, Chen TY, Chen YC, Tan TD, Hsieh CY, Lin C, Lai C, Miljkovic D, Chang CS. Kuo CY, et al. Ther Adv Hematol. 2018 Mar;9(3):65-78. doi: 10.1177/2040620718756603. Epub 2018 Mar 4. Ther Adv Hematol. 2018. PMID: 29531660 Free PMC article.
A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia.
Limsuwanachot N, Rerkamnuaychoke B, Niparuck P, Singdong R, Kongruang A, Hirunpatrawong P, Siriyakorn T, Yenchitsomanus PT, Siriboonpiputtana T. Limsuwanachot N, et al. J Mass Spectrom Adv Clin Lab. 2023 Apr 13;28:122-132. doi: 10.1016/j.jmsacl.2023.04.002. eCollection 2023 Apr. J Mass Spectrom Adv Clin Lab. 2023. PMID: 37128502 Free PMC article.
The role of Down syndrome cell adhesion molecule in Down syndrome.
Hergenreder T, Yang T, Ye B. Hergenreder T, et al. Med Rev (2021). 2024 Feb 9;4(1):31-41. doi: 10.1515/mr-2023-0056. eCollection 2024 Feb. Med Rev (2021). 2024. PMID: 38515781 Free PMC article. Review.
SHP-2 is a novel target of Abl kinases during cell proliferation.
Mitra S, Beach C, Feng GS, Plattner R. Mitra S, et al. J Cell Sci. 2008 Oct 15;121(Pt 20):3335-46. doi: 10.1242/jcs.035691. Epub 2008 Sep 30. J Cell Sci. 2008. PMID: 18827006 Free PMC article.
Heat shock proteins in breast cancer progression--a suitable case for treatment?
Calderwood SK. Calderwood SK. Int J Hyperthermia. 2010;26(7):681-5. doi: 10.3109/02656736.2010.490254. Int J Hyperthermia. 2010. PMID: 20653417 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal